(2R)-2-Hydroxybutanoic acid | CAS:20016-85-7

We serve (2R)-2-Hydroxybutanoic acid CAS:20016-85-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(2R)-2-Hydroxybutanoic acid

Chemical Name:(2R)-2-Hydroxybutanoic acid
CAS.NO:20016-85-7
Synonyms:(2R)-2-Hydroxybutanoic acid
(R)-2-Hydroxybutyric acid
(R)-2-hydroxylbutanoic acid
(R)-(+)-2-Hydroxybutanoic acid
D-2-hydroxybutyric acid
(R)-hydroxybutyric acid
 
Physical and Chemical Properties:
Density 1.195g/cm3
Boiling Point 238.3ºC at 760 mmHg
Melting Point 50-54ºC
Molecular Formula C4H8O3
Molecular Weight 104.10500
Flash Point 112.2ºC
Vapour Pressure 0.00759mmHg at 25°C
Index of Refraction 1.455
 
Specification:
Appearance:White crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Idelalisib(CAS:870281-82-6).



Contact us for information like (2R)-2-Hydroxybutanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-hydroxybutyric acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(R)-2-hydroxylbutanoic acid Use and application,D-2-hydroxybutyric acid technical grade,usp/ep/jp grade.


Related News: This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy.1-Methyl-3-phenylpiperazine manufacturer High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies.DL-Norvaline supplier China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.3-Methyl-1-butanethiol vendor China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.Over the past few days, there’s been a question dominating Chinese social media: Could a traditional Chinese medicine help fight the Wuhan coronavirus?